{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:39:44Z","timestamp":1784932784556,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["UID 129135"],"award-info":[{"award-number":["UID 129135"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_214897"],"award-info":[{"award-number":["310030_214897"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008949","name":"Uniscientia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI155412"],"award-info":[{"award-number":["R01AI155412"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD102487"],"award-info":[{"award-number":["R01HD102487"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017659","name":"Uniscientia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.exppara.2023.108655","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T23:41:59Z","timestamp":1700264519000},"page":"108655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice"],"prefix":"10.1016","volume":"255","author":[{"given":"Carling","family":"Schlange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Pascal Alexander","family":"H\u00e4nggeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghalia","family":"Boubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis-Miguel","family":"Ortega-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Ning","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley C.","family":"Van Voorhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-2128","authenticated-orcid":false,"given":"Andrew","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2023.108655_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.exppara.2023.108655_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol Drugs Drug Res"},{"key":"10.1016\/j.exppara.2023.108655_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106099","article-title":"Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice","volume":"56","author":"Anghel","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2023.108655_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpddr.2021.08.007","article-title":"Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo","volume":"17","author":"Anghel","year":"2021","journal-title":"Int J Parasitol Drugs Drug Res"},{"key":"10.1016\/j.exppara.2023.108655_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s13071-020-04445-z","article-title":"The life-cycle of Toxoplasma gondii reviewed using animations","volume":"13","author":"Attias","year":"2020","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.exppara.2023.108655_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.chom.2009.05.017","article-title":"Calcium-dependent signaling and kinases in apicomplexan parasites","volume":"5","author":"Billker","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.exppara.2023.108655_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpara.2020.01.006","article-title":"Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned","volume":"50","author":"Choi","year":"2020","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02214-17","article-title":"Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in Plasmodium falciparum transmissible gametocyte stages","volume":"62","author":"Coertzen","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108655_bib10","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.38.8.2929-2932.2000","article-title":"Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes","volume":"38","author":"Costa","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.exppara.2023.108655_bib11","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.3390\/molecules25153505","article-title":"Safety of artemisinin derivatives in the first trimester of pregnancy: a controversial story","volume":"25","author":"D'Alessandro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.exppara.2023.108655_bib12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/pathogens10111351","article-title":"Comprehensive overview of Toxoplasma gondii-induced and associated diseases","volume":"10","author":"Daher","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.exppara.2023.108655_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00054","article-title":"Toxoplasmosis: overview from a one health perspective","volume":"15","author":"Djurkovi\u0107-Djakovi\u0107","year":"2019","journal-title":"Food Waterborne Parasitol"},{"key":"10.1016\/j.exppara.2023.108655_bib14","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1021\/acs.jmedchem.6b01586","article-title":"Structure-activity relationship of the antimalarial ozonide artefenomel (OZ439)","volume":"60","author":"Dong","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2023.108655_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02065-21","article-title":"Dimeric artesunate glycerophosphocholine conjugate nano-assemblies as slow-release antimalarials to overcome kelch 13 mutant artemisinin resistance","volume":"66","author":"Du","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108655_bib16","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/AAC.00502-09","article-title":"Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model","volume":"53","author":"Dunay","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.exppara.2023.108655_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2023.108655_bib18","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3390\/pharmaceutics13122066","article-title":"The artemiside-artemisox-artemisone-M1 tetrad: efficacies against blood stage P. falciparum parasites, DMPK properties, and the case for artemiside","volume":"13","author":"Gibhard","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exppara.2023.108655_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/hiv.12402","article-title":"A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?","volume":"18","author":"Hernandez","year":"2017","journal-title":"HIV Med."},{"key":"10.1016\/j.exppara.2023.108655_bib20","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/acs.jmedchem.9b00069","article-title":"Development of 5-Aminopyrazole-4-carboxamide-based bumped-kinase inhibitors for cryptosporidiosis therapy","volume":"62","author":"Huang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2023.108655_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpddr.2021.05.001","article-title":"In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts","volume":"16","author":"Imhof","year":"2021","journal-title":"Int J Parasitol Drugs Drug Res"},{"key":"10.1016\/j.exppara.2023.108655_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijpara.2017.08.005","article-title":"In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites","volume":"47","author":"Jim\u00e9nez-Mel\u00e9ndez","year":"2017","journal-title":"Int. J. Parasitol."},{"issue":"6","key":"10.1016\/j.exppara.2023.108655_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4065\/mcp.2011.0203","article-title":"Antiparasitic therapy","volume":"86","author":"Kappagoda","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.exppara.2023.108655_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cvfa.2019.11.004","article-title":"Neosporosis, toxoplasmosis, and sarcocystosis in ruminants: an update","volume":"36","author":"Lindsay","year":"2020","journal-title":"Vet Clin North Am Food Anim Pract"},{"key":"10.1016\/j.exppara.2023.108655_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2307\/3283832","article-title":"Ultrastructural effects of diclazuril against Toxoplasma gondii and investigation of a diclazuril-resistant mutant","volume":"81","author":"Lindsay","year":"1995","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.012","article-title":"Artemisinin and its derivatives in treating protozoan infections beyond malaria","volume":"117","author":"Loo","year":"2017","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.exppara.2023.108655_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.41.9.1849","article-title":"Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro","volume":"41","author":"McFadden","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108655_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/pim.12398","article-title":"Development of vaccines for parasitic diseases of animals: challenges and opportunities","volume":"38","author":"Morrison","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.exppara.2023.108655_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpara.2012.08.004","article-title":"In vitro culture systems for the study of apicomplexan parasites in farm animals","volume":"43","author":"M\u00fcller","year":"2013","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2022.11.005","article-title":"Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation","volume":"21","author":"M\u00fcller","year":"2023","journal-title":"Int. J. Parasitol. Drugs. Drug. Resist."},{"key":"10.1016\/j.exppara.2023.108655_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092929","article-title":"Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy","volume":"9","author":"Ojo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2023.108655_bib33","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijpara.2016.08.003","article-title":"Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy","volume":"46","author":"Ojo","year":"2016","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/pathogens7020033","article-title":"Acidocalcisome-mitochondrion membrane contact sites in Trypanosoma brucei","volume":"7","author":"Ramakrishnan","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.exppara.2023.108655_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2023.108655_bib36","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1242\/jeb.00589","article-title":"Antimalarial drug discovery: old and new approaches","volume":"206","author":"Rosenthal","year":"2003","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.exppara.2023.108655_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fcimb.2018.00436","article-title":"Virulence in mice of a Toxoplasma gondii type II isolate does not correlate with the outcome of experimental infection in pregnant sheep","volume":"8","author":"S\u00e1nchez-S\u00e1nchez","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.exppara.2023.108655_bib38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.exppara.2023.108655_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178691","article-title":"The use of Gompertz models in growth analyses, and new Gompertz-model approach: an addition to the Unified-Richards family","volume":"12","author":"Tjorve","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2023.108655_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exppara.2017.01.001","article-title":"Extended-spectrum antiprotozoal bumped kinase inhibitors: a review","volume":"180","author":"Van Voorhis","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2020.109336","article-title":"One health therapeutics: target-Based drug development for cryptosporidiosis and other apicomplexa diseases","volume":"289","author":"Van Voorhis","year":"2021","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2023.108655_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00990-21","article-title":"Toward new transmission-blocking combination therapies: pharmacokinetics of 10-amino-artemisinins and 11-aza-artemisinin and comparison with dihydroartemisinin and artemether","volume":"65","author":"Watson","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108655_bib45","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01236-15","article-title":"In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum","volume":"59","author":"Winzer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108655_bib46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/pathogens9050382","article-title":"Neospora caninum: structure and fate of multinucleated complexes induced by the bumped kinase inhibitor BKI-1294","volume":"9","author":"Winzer","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.exppara.2023.108655_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/microorganisms8060801","article-title":"Neospora caninum: differential proteome of multinucleated complexes induced by the bumped kinase inhibitor BKI-1294","volume":"8","author":"Winzer","year":"2020","journal-title":"Microorganisms"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489423001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489423001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:04:42Z","timestamp":1762149882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489423001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"alternative-id":["S0014489423001960"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2023.108655","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2023.108655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108655"}}